Cytokine-induced alterations of gastrointestinal motility in gastrointestinal disorders.
about
Proinflammatory Cytokines and Potassium Channels in the KidneyMesalamine in the treatment and maintenance of remission of ulcerative colitisNew insights into the pathophysiology of achalasia and implications for future treatmentEffect of acute stress on immune cell counts and the expression of tight junction proteins in the duodenal mucosa of rats.Curcuma longa extract exerts a myorelaxant effect on the ileum and colon in a mouse experimental colitis model, independent of the anti-inflammatory effectWhat does irritable bowel syndrome share with non-alcoholic fatty liver disease?Colitis-induced neuroplasticity disrupts motility in the inflamed and post-inflamed colon.Mechanical stress is a pro-inflammatory stimulus in the gut: in vitro, in vivo and ex vivo evidence.Achalasia--An Autoimmune Inflammatory Disease: A Cross-Sectional Study.Update on the management of ulcerative colitis: treatment and maintenance approaches focused on MMX(®) mesalamine.Change in gastric emptying eight weeks after endoscopic submucosal dissection in patients with early gastric cancer.Immune/Inflammatory Response and Hypocontractility of Rabbit Colonic Smooth Muscle After TNBS-Induced Colitis.Changes in the expression of smooth muscle contractile proteins in TNBS- and DSS-induced colitis in mice.Increased activation of latent TGF-β1 by αVβ3 in human Crohn's disease and fibrosis in TNBS colitis can be prevented by cilengitide.Pathogenesis of achalasia cardia.Crohn's disease: small bowel motility impairment correlates with inflammatory-related markers C-reactive protein and calprotectin.Crosstalk at the mucosal border: importance of the gut microenvironment in IBS.Acute colonic pseudo-obstruction: A systematic review of aetiology and mechanisms.Effects of traumatic brain injury on intestinal contractility.Conservative treatment for lumbar compartment syndrome shows efficacy over 2-year follow-up: a case report and literature review.Regional gastrointestinal transit times in severe ulcerative colitis.Resiniferatoxin lowers TNF-α, NO and PGE2 in the intestinal phase and the parasite burden in the muscular phase of Trichinella spiralis infection.TH17 predominant T-cell responses in radiation-induced bowel disease are modulated by treatment with adipose-derived mesenchymal stromal cells.Factors associated with clinical failure of self-expandable metal stent for malignant gastroduodenal obstruction.Advances and challenges in the management of acute colonic pseudo-obstruction (ogilvie syndrome).Signalling mechanisms in PAF-induced intestinal failure.Preserved gastric motility in patients with early gastric cancer after endoscopic submucosal dissection.Carcinomatosis matters: clinical outcomes and prognostic factors for clinical success of stent placement in malignant gastric outlet obstruction.Therapeutic Effects of Resiniferatoxin Related with Immunological Responses for Intestinal Inflammation in Trichinellosis.CCR7 deficiency causes diarrhea associated with altered ion transport in colonocytes in the absence of overt colitis.
P2860
Q26778327-A75A1FFE-A42F-4F6C-B97D-053F8F65010AQ26865546-855AAC1E-C936-4D3A-BB29-8FE08E43FFE3Q28068914-518C3DDE-4E8C-4BDD-9AF4-D5D8AE828078Q30455649-110B44E7-24DB-4954-87BB-31C1CE3F2B91Q34416022-D2BCC791-070D-49C0-A6EA-63384568B436Q34983471-463B3EE0-2F4E-4509-8BAE-54BAF4933C8DQ35183955-E25984F5-8D7C-4416-A022-AC8F353581FDQ35236744-10E4EC2A-6DF8-4483-8842-E0B85F753F0FQ35675896-60F772FD-1EF6-459C-9ACA-26C08E7EE61DQ36144377-08C6AEAA-12F2-436D-8F56-263E8FF45050Q36921950-221A0977-EC4B-4511-80C1-5B1330ACB079Q37037428-C86DB27E-CC05-4D42-BABF-F6DA456AC88AQ37297153-F48D32E5-ED50-45F2-92D5-CE5EC5AA93A3Q37469875-BA420331-8503-43F7-A563-4868193EFEEDQ38026029-7AA7052E-9ED8-4F0B-8C98-753967C733D4Q38089781-0A5FD012-89DB-4175-929D-67B4AC2A1486Q38275041-79906304-99F9-4137-80BA-DF4194AB9829Q38635865-5F81F7B1-2CCD-443E-B316-1E203DFAEC6CQ38696682-BC16516B-8357-4B33-B9C5-6D22BCEA2809Q39389908-F868A922-D7A1-4F17-8B6F-9DA91D643D5EQ40146897-DC8E4BEC-683A-47ED-8DD2-09EE365AFCE1Q40506129-5EFE2E74-113A-4306-B8AC-05FF1D4E2288Q40733169-97C7FB5A-BFD0-435F-9C4A-CB2CEA5E3B6DQ40771760-37A6121E-AF56-4E18-8E9C-D556F945250CQ42154974-BF3B92B9-C0F3-48CD-B23D-2DD2CA3644AAQ42683441-03AF947B-DC5E-4871-BD4A-8D302327EAF1Q43443752-90A594B0-2EB4-4D8B-A8FE-499E0E581633Q44854647-EB4CBE23-491A-4BC0-BC73-745F24ADAAFBQ47555989-E051A06C-DEB9-474E-8C1C-DA791A2C64E1Q52889308-411CC964-4696-4F44-B180-4A08A8C15181
P2860
Cytokine-induced alterations of gastrointestinal motility in gastrointestinal disorders.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Cytokine-induced alterations of gastrointestinal motility in gastrointestinal disorders.
@en
Cytokine-induced alterations of gastrointestinal motility in gastrointestinal disorders.
@nl
type
label
Cytokine-induced alterations of gastrointestinal motility in gastrointestinal disorders.
@en
Cytokine-induced alterations of gastrointestinal motility in gastrointestinal disorders.
@nl
prefLabel
Cytokine-induced alterations of gastrointestinal motility in gastrointestinal disorders.
@en
Cytokine-induced alterations of gastrointestinal motility in gastrointestinal disorders.
@nl
P2093
P2860
P356
P1476
Cytokine-induced alterations of gastrointestinal motility in gastrointestinal disorders.
@en
P2093
Hirotada Akiho
Kazuhiko Nakamura
Yasuaki Motomura
P2860
P356
10.4291/WJGP.V2.I5.72
P577
2011-10-01T00:00:00Z